Associate Professor, Medicine, University of Colorado School of Medicine
Internal Medicine
Dr. Raymond O. Estacio, MD
|
|
Give Review
Doctor Raymond O. Estacio, MD is an expert in the field of Internal Medicine. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He over the years received 2 awards: "Physician Practice Connections Recognition Program" and "Patient-Centered Medical Home Recognition Program". Raymond Estacio is a published doctor. He has 55 publications published. The most current publication "Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial."
Publications
- Health Promotion Text Messaging Preferences and Acceptability Among the Medically Underserved.
- Effectiveness of a Community Health Worker Cardiovascular Risk Reduction Program in Public Health and Health Care Settings.
- Relation of Reduction in Urinary Albumin Excretion to Ten-Year Cardiovascular Mortality in Patients With Type 2 Diabetes and Systemic Hypertension.
- Impact of Cardiovascular Disease Guideline Dissemination on Provider Knowledge.
- Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors.
- Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension.
- Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
- Design of a nurse-run, telephone-based intervention to improve lipids in diabetics.
- Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.
- Heart rate recovery predicts mortality and cardiovascular events in patients with type 2 diabetes.
- Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative.
- Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
- Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance.
- Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention.
- Angiotensin-converting enzyme inhibitors and myocardial infarction: a class effect?
- Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes.
- Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes.
- Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
- Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertension.
- Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension.
- Testing electronic algorithms to create disease registries in a safety net system.
- Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.
- Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus.
- Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
- Diabetic autonomic neuropathy is associated with an increased incidence of strokes.
- The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized...
- Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease.
- Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
- Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy.
- JNC VI guidelines.
- The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
- The association between diabetic complications and exercise capacity in NIDDM patients.
- Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM.
- Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
- Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.
- Clinical factors associated with urinary albumin excretion in type II diabetes.
- The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
- Effect of risk factors on exercise capacity in NIDDM.
- Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial.
- Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
- Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
- Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
- Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.
- Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.
- Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes.
- Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity.
- Serum phosphorus and cardiovascular mortality in type 2 diabetes.
- Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.
- Injury and death associated with incidents reported to the patient safety net.
- Reducing cardiovascular disease risk using patient navigators, Denver, Colorado, 2007-2009.
- Treatment of high-risk diabetic patients with angiotensin II receptor blockers.
- Smoking and abnormalities in renal function.
- Associations of hypertension and complications in non-insulin-dependent diabetes mellitus.
- Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus.
Schools
Indiana University School Of Medicine
University Of Co School Of Med
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- First Health (Coventry Health Care) PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Physician Practice Connections Recognition Program
- Patient-Centered Medical Home Recognition Program
Education
-
University of Colorado -
Indiana University School of Medicine
Hospital
-
Denver Health
Helpful Reviews
Similar Doctors
|
|
Dr. Amber D. Wobbekind, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin T. Briggs, MD |
|
|
Dr. Melver L. Anderson III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy N. Tidwell, MD |
|
|
Dr. David S. Brody, MD |
|
Dr. Yelena Anisimova, MD |
|
|
Dr. Caroline S. Miles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shabnam O. Showell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristin E. Haber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald R. Rollins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary A. Friedland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Kolpak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott H. Kubowicz, MD
This Doctor is OpenDoctor Recommended.
|